BioLASCO Taiwan Co., Ltd.
Research BioLASCO Taiwan Co., Ltd. (6662.TWO) on Bullrun: market cap TWD 722.26M, P/E 17.7, dividend yield 5.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6662.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 722.26M
- P/E17.7
- Dividend yield5.5%
- Financial periodQ2 2026
- RevenueTWD 64.51M
- Net incomeTWD 10.38M
- Free cash flowTWD 14.96M
- Gross margin40.2%
Valuation Snapshot
latest market cap is TWD 722.26M; P/E is 17.7; dividend yield is 5.5%.
Peer valuation comparison
Latest P/E is 17.74x versus a Healthcare sector median of 21.8x (18.6% below).
Latest dividend yield is 5.46% versus a Healthcare sector median of 2.4% (127.5% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 722.26M | 17.7 | 5.5% | 1.55 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.55 TWD, yield 5.5%.
About BioLASCO Taiwan Co., Ltd.
BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory animals in Taiwan and internationally. The company offers lab animals, such as rat, mice, and others, as well as surgical services; and rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BioLASCO Taiwan Co., Ltd.'s market cap?
BioLASCO Taiwan Co., Ltd.'s market capitalization is TWD 722.26M.
What is BioLASCO Taiwan Co., Ltd.'s P/E ratio?
BioLASCO Taiwan Co., Ltd.'s price-to-earnings (P/E) ratio is 17.7.
Does BioLASCO Taiwan Co., Ltd. pay a dividend?
BioLASCO Taiwan Co., Ltd. has a dividend yield of 5.5%.
What does BioLASCO Taiwan Co., Ltd. do?
BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory animals in Taiwan and internationally. The company offers lab animals, such as rat, mice, and others, as well as surgical services; and rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment.